Jetzt neu! Crypto CFDs von Plus500 auf Axie Infinity, Chainlink, Uniswap & Filecoin. Jetzt in der Demo kostenlos ausprobieren!*-w-
09.08.2022 00:26:22

Why Novavax Stock Got Mashed on Monday

Novavax (NASDAQ: NVAX), an up-and-down coronavirus stock, had a down day on Monday. The vaccine specialist's share price took a 5% hit after the company reported earnings that fell short of expectations.For its second quarter, Novavax earned just under $186 million in total revenue, which was well under the more than $298 million in the same period last year. Although the company recorded over $55 million in product sales compared to $0 in the year-ago frame, the amount in grants it received fell by more than 60% to less than $108 million.That reduced revenue figure, combined with steeper costs, plunged the company more deeply into the red on the bottom line. Novavax booked a net loss in excess of $510 million ($6.53 per share) against the second quarter 2021 shortfall of $352 million.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

Analysen zu Onmehr Analysen

Eintrag hinzufügen

Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Novavax Inc. 20,88 -4,11% Novavax Inc.
On 16,93 2,23% On
pagehit